Mirion Technologies (NYSE:MIR – Get Free Report) was upgraded by research analysts at Melius Research to a “strong-buy” rating in a research note issued to investors on Monday,Zacks.com reports.
A number of other equities analysts also recently weighed in on MIR. JPMorgan Chase & Co. cut their target price on Mirion Technologies from $33.00 to $30.00 and set an “overweight” rating on the stock in a research note on Monday, March 9th. Morgan Stanley decreased their price target on Mirion Technologies from $29.00 to $27.00 and set an “equal weight” rating for the company in a research report on Wednesday, March 11th. Citigroup dropped their price target on Mirion Technologies from $32.00 to $29.00 and set a “buy” rating on the stock in a report on Thursday, February 12th. The Goldman Sachs Group cut their price objective on Mirion Technologies from $33.00 to $29.00 and set a “buy” rating on the stock in a research report on Thursday, February 12th. Finally, Evercore started coverage on Mirion Technologies in a research report on Tuesday, November 25th. They set an “outperform” rating and a $29.00 target price for the company. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $27.63.
Get Our Latest Research Report on Mirion Technologies
Mirion Technologies Stock Performance
Mirion Technologies (NYSE:MIR – Get Free Report) last released its quarterly earnings results on Tuesday, February 10th. The company reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.01). Mirion Technologies had a return on equity of 6.97% and a net margin of 3.11%.The firm had revenue of $277.40 million for the quarter, compared to analysts’ expectations of $281.17 million. During the same quarter last year, the firm posted $0.17 earnings per share. The firm’s revenue for the quarter was up 9.1% compared to the same quarter last year. Mirion Technologies has set its FY 2026 guidance at 0.500-0.570 EPS. Equities research analysts forecast that Mirion Technologies will post 0.39 EPS for the current fiscal year.
Institutional Investors Weigh In On Mirion Technologies
A number of hedge funds have recently modified their holdings of MIR. EverSource Wealth Advisors LLC raised its holdings in shares of Mirion Technologies by 25.2% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 2,056 shares of the company’s stock worth $48,000 after purchasing an additional 414 shares during the period. US Bancorp DE grew its holdings in Mirion Technologies by 6.6% during the third quarter. US Bancorp DE now owns 6,874 shares of the company’s stock valued at $160,000 after purchasing an additional 425 shares during the period. Stratos Wealth Partners LTD. increased its position in Mirion Technologies by 4.8% in the fourth quarter. Stratos Wealth Partners LTD. now owns 10,567 shares of the company’s stock worth $247,000 after buying an additional 484 shares during the last quarter. Kennedy Capital Management LLC increased its position in Mirion Technologies by 0.4% in the fourth quarter. Kennedy Capital Management LLC now owns 125,076 shares of the company’s stock worth $2,929,000 after buying an additional 505 shares during the last quarter. Finally, Nisa Investment Advisors LLC raised its stake in shares of Mirion Technologies by 16.1% in the third quarter. Nisa Investment Advisors LLC now owns 3,909 shares of the company’s stock valued at $91,000 after buying an additional 543 shares during the period. Institutional investors own 78.51% of the company’s stock.
Mirion Technologies Company Profile
Mirion Technologies Inc (NYSE: MIR) is a leading global provider of radiation detection, measurement and monitoring solutions. The company’s portfolio includes instrumentation, software and service offerings designed to detect, quantify and manage radiation in nuclear power, oil and gas, defense and homeland security, medical imaging and diagnostic applications. Mirion’s product suite spans personal and environmental dosimetry, area monitors, digital imaging detectors and turnkey solutions for decommissioning and environmental remediation projects.
Mirion traces its origins to the combination of several established radiation measurement businesses, including the former Canberra nuclear instrumentation division, and has been supported by private equity investors before completing its initial public offering on the New York Stock Exchange in 2023.
Further Reading
Receive News & Ratings for Mirion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mirion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
